If you or someone you know has experienced uncontrollable bleeding after taking Eliquis, you could be in need of an Eliquis lawyer.

Bristol-Myers Squibb and Pfizer manufacture Eliquis, generically known as apixaban.

Eliquis has been marketed as superior to older blood thinner Coumadin (warfarin). Eliquis is touted as a once daily oral medication that does not need patient monitoring like Coumadin does.

Eliquis works by blocking a blood-clotting factor called Xa.

Eliquis Lawyer Can Fight Claim That New Drug Is Better Than Coumadin

The right Eliquis lawyer can make a case for you that shows Eliquis is not safer than Coumadin.  (Coumadin can have its anticoagulant effects reversed by introducing vitamin K.)

Evidence includes that from Dr. Curt Furberg, a medical advisor to the Institute for Safe Medication Practices (ISMP), a nonprofit organization dedicated to educating the healthcare community and the public about medication safety.

Dr. Furberg says that the new blood thinners such as Eliquis have a wide variation of clot-preventing effects, depending upon the patient.

Research shows that while a certain dose of Eliquis might work well for some patients, that same dose might be too low to effectively stop a blood clot from forming in other patients. Even worse, that identical dose could lead to an Eliquis fatal bleeding episode in yet another patient.

Eliquis Pushed Way Through FDA Approval Process

An Eliquis lawyer will know that the medicine was the last of the new blood thinners to be approved by the FDA.

An Eiliquis clinical trial known as ARISTOTLE (Apixaban for Reduction in Stroke and Other Thrombotic Events in Atrial Fibrillation) was widely criticized. There were accusations of alleged cover-ups, unreported serious adverse events (including one death), and patients who received the wrong medication.

The FDA said that the drug’s clinical trial issues showed problems that demonstrated a “pattern of inadequate trial conduct and oversight.”

The FDA faulted the study for containing inaccurate data, and the data in the English version did not match the data presented in the Chinese language.

In December 2012, the FDA approved Eliquis after deciding other clinical trial results adequately showed the drug’s effectiveness.

Eliquis Fatal Bleeding Issues

Eliquis has no antidote. If a patient takes Eliquis and starts to have uncontrollable bleeding, there is little a doctor can do.

On the Eliquis website, it says, “…bleeding can be more serious and rarely may lead to death…”

If you take certain other medications, the risk of bleeding increases. Taking aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), warfarin, heparin, selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine uptake inhibitors (SNRIs) can increase the chances of dangerous bleeding.

If you or someone you know has taken Eliquis and suffered bleeding side effects, you could benefit from speaking with an Eliquis lawyer.